Explore 2-Methyl-5-methoxy-N-allyl-N-cyclohexyltryptamine | PiHKAL · info

Exploring 2-Methyl-5-methoxy-N-allyl-N-cyclohexyltryptamine. To explore a different substance…

Name

2-Methyl-5-methoxy-N-allyl-N-cyclohexyltryptamine

IUPAC name

N-[2-(5-Methoxy-2-methyl-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)cyclohexanamine

ID 5583 · Formula C₂₁H₃₀N₂O · Molecular weight 326.476

Tags Tryptamine

InChI InChI=1S/C21H30N2O/c1-4-13-23(17-8-6-5-7-9-17)14-12-19-16(2)22-21-11-10-18(24-3)15-20(19)21/h4,10-11,15,17,22H,1,5-9,12-14H2,2-3H3

InChI Key GTNZSRHBGNZTSV-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES COc1ccc2c(c1)c(CCN(C1CCCCC1)CC=C)c([nH]2)C

PubChem 129850420

Brandt, SD; Tearavarich, R; Dempster, N; Cozzi, NV; Daley, PF. Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines Drug Test. Anal., 1 Jan 2012, 4 (1), 24–32. 506 kB. https://doi.org/10.1002/dta.398 #12 MS,NMR

Meyer, MR; Caspar, A; Brandt, SD; Maurer, HH. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches Anal. Bioanal. Chem., 1 Jan 2014, 406 (1), 225–237. 457 kB. https://doi.org/10.1007/s00216-013-7425-9 #5-MeO-2-Me-ALCHT LC,MS

Caspar, AT; Gaab, JB; Michely, JA; Brandt, SD; Meyer, MR; Maurer, HH. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC–MS, LC–MSn, and LC-HR-MSMS Drug Test. Anal., 1 Jan 2018, 10 (1), 184–195. 546 kB. https://doi.org/10.1002/dta.2197 #A1

5-Ethoxy-N-allyl-N-cyclohexyltryptamine

CHM-PICA · SDB-004

AT-200 · SR14150

7540

SGT-137

SGT-117

CH-PIATA · CHX-PIACA · CHX-PIATA · Cyclohexyl-PIATA

7 Dec 2019 · · Isomer Design